A5086523243- Vaccine Coverage and Hesitancy
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
University of Health Sciences Antigua
2022-2023
Sağlık Bilimleri Üniversitesi
2022-2023
Protective neutralizing antibody titers reduce in time after COVID-19 vaccinations, as individuals who have had COVID-19. This study aimed to evaluate the safety and immunogenicity of CoronaVac TURKOVAC vaccines used a booster dose primary vaccination. double-blind, randomized, controlled, phase II, multicenter included healthy male female adults (18–60 years) were vaccinated with two doses vaccine did not exceed duration at least 90 days maximum 270 from second Among 236 eligible...
The immunogenicity of vaccines decreases over time, causing a need for booster doses. This study aimed to present the long-term (Day 84) results double-blind, randomized, controlled, phase II Hybrid COV-RAPEL TR Study (NCT04979949), in which TURKOVAC or CoronaVac were used as after second dose primary vaccination with CoronaVac. A total 190 participants from Study, who had both Day 28 and 84 results, included. on 84, regarding neutralizing antibody positivity (Wuhan Delta variants)...